Therefore, to impede this pressing trend, it is essential to realize the early diagnosis and therapeutics of prostate cancer for which prostate specific antigen (PSA) has been the most extensively applied directional tumor marker [3]. The gene discussed is KLK3; the disease is prostate cancer.